3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D003024:Clozapine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism*; D007608:Kainic Acid / Q000494:pharmacology; D008297:Male; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D014439:Tyramine / Q000031:analogs & derivatives* / Q000378:metabolism
D014150:Antipsychotic Agents; D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D003024:Clozapine; D006220:Haloperidol; D007608:Kainic Acid; D006719:Homovanillic Acid; D014439:Tyramine